Safeguard Scientifics, Inc. Logo

Safeguard Scientifics, Inc.

SFE

(1.2)
Stock Price

0,46 USD

-53.1% ROA

-44.07% ROE

-0.61x PER

Market Cap.

7.541.898,00 USD

6.25% DER

76.92% Yield

-816.08% NPM

Safeguard Scientifics, Inc. Stock Analysis

Safeguard Scientifics, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Safeguard Scientifics, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.53x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a low debt to equity ratio (5%), which means it has a small amount of debt compared to the ownership it holds

3 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

4 ROE

The stock's ROE indicates a negative return (-52.7%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-50.65%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Safeguard Scientifics, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Safeguard Scientifics, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Safeguard Scientifics, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Safeguard Scientifics, Inc. Revenue
Year Revenue Growth
1985 58.800.000
1986 67.500.000 12.89%
1987 103.300.000 34.66%
1988 284.200.000 63.65%
1989 383.500.000 25.89%
1990 449.100.000 14.61%
1991 644.200.000 30.29%
1992 845.000.000 23.76%
1993 1.168.300.000 27.67%
1994 1.412.000.000 17.26%
1995 1.517.700.000 6.96%
1996 2.062.800.000 26.43%
1997 1.985.200.000 -3.91%
1998 2.275.100.000 12.74%
1999 2.953.300.000 22.96%
2000 2.770.381.000 -6.6%
2001 1.925.668.000 -43.87%
2002 1.685.554.000 -14.25%
2003 1.622.558.000 -3.88%
2004 156.709.000 -935.4%
2005 186.216.000 15.85%
2006 198.060.000 5.98%
2007 176.119.000 -12.46%
2008 73.736.000 -138.85%
2009 34.839.000 -111.65%
2010 34.839.000 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 31.657.000 100%
2015 217.000 -14488.48%
2016 0 0%
2017 0 0%
2018 0 0%
2019 12.255.000 100%
2020 -7.708.000 258.99%
2021 22.035.000 134.98%
2022 -3.297.000 768.33%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Safeguard Scientifics, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 12.717.000 100%
2006 6.977.000 -82.27%
2007 2.407.000 -189.86%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Safeguard Scientifics, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 203.500.000 100%
1995 156.500.000 -30.03%
1996 212.700.000 26.42%
1997 224.100.000 5.09%
1998 269.000.000 16.69%
1999 311.600.000 13.67%
2000 349.557.000 10.86%
2001 315.053.000 -10.95%
2002 141.501.000 -122.65%
2003 111.215.000 -27.23%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 19.473.000 100%
2013 21.644.000 10.03%
2014 18.970.000 -14.1%
2015 17.554.000 -8.07%
2016 18.692.000 6.09%
2017 17.131.000 -9.11%
2018 16.871.000 -1.54%
2019 8.355.000 -101.93%
2020 6.181.000 -35.17%
2021 7.153.000 13.59%
2022 4.617.000 -54.93%
2023 7.996.000 42.26%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Safeguard Scientifics, Inc. EBITDA
Year EBITDA Growth
1985 -4.000.000
1986 -9.400.000 57.45%
1987 -13.900.000 32.37%
1988 -13.100.000 -6.11%
1989 -6.400.000 -104.69%
1990 -40.200.000 84.08%
1991 6.800.000 691.18%
1992 26.400.000 74.24%
1993 41.800.000 36.84%
1994 8.800.000 -375%
1995 19.100.000 53.93%
1996 16.600.000 -15.06%
1997 21.700.000 23.5%
1998 -156.700.000 113.85%
1999 -194.700.000 19.52%
2000 211.216.000 192.18%
2001 7.483.000 -2722.61%
2002 25.805.000 71%
2003 -49.237.000 152.41%
2004 -79.421.000 38.01%
2005 -34.550.000 -129.87%
2006 -46.053.000 24.98%
2007 -34.639.000 -32.95%
2008 -26.744.000 -29.52%
2009 -99.156.000 73.03%
2010 -68.808.000 -44.11%
2011 -152.933.000 55.01%
2012 -19.473.000 -685.36%
2013 -21.644.000 10.03%
2014 -18.970.000 -14.1%
2015 -17.554.000 -8.07%
2016 -18.692.000 6.09%
2017 -17.131.000 -9.11%
2018 1.130.000 1616.02%
2019 -7.536.000 114.99%
2020 -2.896.000 -160.22%
2021 -26.070.000 88.89%
2022 -4.459.000 -484.66%
2023 -3.996.000 -11.59%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Safeguard Scientifics, Inc. Gross Profit
Year Gross Profit Growth
1985 22.200.000
1986 26.500.000 16.23%
1987 37.900.000 30.08%
1988 65.800.000 42.4%
1989 86.700.000 24.11%
1990 103.500.000 16.23%
1991 144.900.000 28.57%
1992 180.800.000 19.86%
1993 227.400.000 20.49%
1994 239.300.000 4.97%
1995 206.300.000 -16%
1996 269.800.000 23.54%
1997 286.000.000 5.66%
1998 302.200.000 5.36%
1999 347.500.000 13.04%
2000 328.539.000 -5.77%
2001 308.267.000 -6.58%
2002 275.456.000 -11.91%
2003 246.032.000 -11.96%
2004 51.710.000 -375.79%
2005 59.306.000 12.81%
2006 55.670.000 -6.53%
2007 51.380.000 -8.35%
2008 40.729.000 -26.15%
2009 21.028.000 -93.69%
2010 21.028.000 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 31.657.000 100%
2015 217.000 -14488.48%
2016 0 0%
2017 0 0%
2018 0 0%
2019 12.255.000 100%
2020 -7.708.000 258.99%
2021 22.035.000 134.98%
2022 -3.297.000 768.33%
2023 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Safeguard Scientifics, Inc. Net Profit
Year Net Profit Growth
1985 3.300.000
1986 5.700.000 42.11%
1987 12.900.000 55.81%
1988 7.200.000 -79.17%
1989 7.300.000 1.37%
1990 15.600.000 53.21%
1991 11.500.000 -35.65%
1992 9.900.000 -16.16%
1993 3.900.000 -153.85%
1994 15.700.000 75.16%
1995 18.300.000 14.21%
1996 19.900.000 8.04%
1997 21.500.000 7.44%
1998 110.100.000 80.47%
1999 123.500.000 10.85%
2000 -212.404.000 158.14%
2001 -499.100.000 57.44%
2002 -150.483.000 -231.67%
2003 -33.331.000 -351.48%
2004 -54.820.000 39.2%
2005 -32.070.000 -70.94%
2006 46.030.000 169.67%
2007 -64.833.000 171%
2008 -52.013.000 -24.65%
2009 67.610.000 176.93%
2010 27.114.000 -149.35%
2011 110.597.000 75.48%
2012 -39.362.000 380.97%
2013 -35.525.000 -10.8%
2014 -5.149.000 -589.94%
2015 -59.524.000 91.35%
2016 -22.262.000 -167.38%
2017 -88.572.000 74.87%
2018 -15.629.000 -466.72%
2019 41.763.000 137.42%
2020 -34.069.000 222.58%
2021 46.426.000 173.38%
2022 -23.751.000 295.47%
2023 -17.656.000 -34.52%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Safeguard Scientifics, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 1 100%
1995 1 0%
1996 1 0%
1997 0 0%
1998 2 100%
1999 2 0%
2000 -11 118.18%
2001 -26 56%
2002 -8 -257.14%
2003 -2 -600%
2004 -3 50%
2005 -2 -100%
2006 2 150%
2007 -3 166.67%
2008 -3 -50%
2009 3 166.67%
2010 1 -200%
2011 5 80%
2012 -2 600%
2013 -2 0%
2014 0 0%
2015 -3 100%
2016 -1 -100%
2017 -4 75%
2018 -1 0%
2019 2 100%
2020 -2 300%
2021 2 150%
2022 -1 300%
2023 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Safeguard Scientifics, Inc. Free Cashflow
Year Free Cashflow Growth
1985 14.200.000
1986 0 0%
1988 0 0%
1989 0 0%
1990 -41.200.000 100%
1991 -24.100.000 -70.95%
1992 15.300.000 257.52%
1993 -13.300.000 215.04%
1994 -33.100.000 59.82%
1995 8.500.000 489.41%
1996 -86.000.000 109.88%
1997 187.600.000 145.84%
1998 102.600.000 -82.85%
1999 -23.200.000 542.24%
2000 -82.332.000 71.82%
2001 193.284.000 142.6%
2002 11.427.000 -1591.47%
2003 -103.924.000 111%
2004 -59.017.000 -76.09%
2005 -35.584.000 -65.85%
2006 -38.668.000 7.98%
2007 -47.102.000 17.91%
2008 -26.099.000 -80.47%
2009 -21.327.000 -22.38%
2010 -16.125.000 -32.26%
2011 -17.785.000 9.33%
2012 -16.598.000 -7.15%
2013 -21.258.000 21.92%
2014 -20.248.000 -4.99%
2015 -19.605.000 -3.28%
2016 -19.093.000 -2.68%
2017 -5.704.000 -234.73%
2018 -26.034.000 78.09%
2019 -19.970.000 -30.37%
2020 -8.143.000 -145.24%
2021 -8.152.000 0.11%
2022 -3.258.000 -150.21%
2023 -818.000 -298.29%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Safeguard Scientifics, Inc. Operating Cashflow
Year Operating Cashflow Growth
1985 14.200.000
1986 0 0%
1988 0 0%
1989 0 0%
1990 -32.200.000 100%
1991 -18.400.000 -75%
1992 30.200.000 160.93%
1993 1.300.000 -2223.08%
1994 -21.300.000 106.1%
1995 19.800.000 207.58%
1996 -36.000.000 155%
1997 218.900.000 116.45%
1998 169.900.000 -28.84%
1999 128.300.000 -32.42%
2000 -66.821.000 292.01%
2001 216.612.000 130.85%
2002 22.951.000 -843.8%
2003 -90.179.000 125.45%
2004 -48.061.000 -87.63%
2005 -23.092.000 -108.13%
2006 -20.548.000 -12.38%
2007 -37.610.000 45.37%
2008 -22.569.000 -66.64%
2009 -19.170.000 -17.73%
2010 -16.019.000 -19.67%
2011 -17.727.000 9.64%
2012 -16.525.000 -7.27%
2013 -21.221.000 22.13%
2014 -20.189.000 -5.11%
2015 -17.749.000 -13.75%
2016 -18.661.000 4.89%
2017 -20.805.000 10.31%
2018 -26.035.000 20.09%
2019 -19.970.000 -30.37%
2020 -8.143.000 -145.24%
2021 -8.152.000 0.11%
2022 -3.258.000 -150.21%
2023 -818.000 -298.29%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Safeguard Scientifics, Inc. Capital Expenditure
Year Capital Expenditure Growth
1985 0
1986 0 0%
1988 0 0%
1989 0 0%
1990 9.000.000 100%
1991 5.700.000 -57.89%
1992 14.900.000 61.74%
1993 14.600.000 -2.05%
1994 11.800.000 -23.73%
1995 11.300.000 -4.42%
1996 50.000.000 77.4%
1997 31.300.000 -59.74%
1998 67.300.000 53.49%
1999 151.500.000 55.58%
2000 15.511.000 -876.73%
2001 23.328.000 33.51%
2002 11.524.000 -102.43%
2003 13.745.000 16.16%
2004 10.956.000 -25.46%
2005 12.492.000 12.3%
2006 18.120.000 31.06%
2007 9.492.000 -90.9%
2008 3.530.000 -168.9%
2009 2.157.000 -63.65%
2010 106.000 -1934.91%
2011 58.000 -82.76%
2012 73.000 20.55%
2013 37.000 -97.3%
2014 59.000 37.29%
2015 1.856.000 96.82%
2016 432.000 -329.63%
2017 -15.101.000 102.86%
2018 -1.000 -1510000%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Safeguard Scientifics, Inc. Equity
Year Equity Growth
1985 25.600.000
1986 32.400.000 20.99%
1987 52.700.000 38.52%
1988 63.600.000 17.14%
1989 65.900.000 3.49%
1990 94.700.000 30.41%
1991 109.400.000 13.44%
1992 120.200.000 8.99%
1993 114.600.000 -4.89%
1994 158.100.000 27.51%
1995 219.900.000 28.1%
1996 254.400.000 13.56%
1997 307.300.000 17.21%
1998 442.800.000 30.6%
1999 677.500.000 34.64%
2000 1.010.899.000 32.98%
2001 531.422.000 -90.23%
2002 402.657.000 -31.98%
2003 378.330.000 -6.43%
2004 217.455.000 -73.98%
2005 175.453.000 -23.94%
2006 217.372.000 19.28%
2007 157.331.000 -38.16%
2008 104.710.000 -50.25%
2009 190.507.000 45.04%
2010 246.936.000 22.85%
2011 348.280.000 29.1%
2012 313.971.000 -10.93%
2013 284.661.000 -10.3%
2014 257.827.000 -10.41%
2015 195.505.000 -31.88%
2016 169.777.000 -15.15%
2017 81.796.000 -107.56%
2018 66.979.000 -22.12%
2019 101.741.000 34.17%
2020 62.875.000 -61.81%
2021 50.566.000 -24.34%
2022 34.576.000 -46.25%
2023 19.980.000 -73.05%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Safeguard Scientifics, Inc. Assets
Year Assets Growth
1985 69.900.000
1986 128.400.000 45.56%
1987 208.000.000 38.27%
1988 264.400.000 21.33%
1989 288.300.000 8.29%
1990 300.000.000 3.9%
1991 388.200.000 22.72%
1992 425.500.000 8.77%
1993 542.800.000 21.61%
1994 617.200.000 12.05%
1995 742.900.000 16.92%
1996 936.100.000 20.64%
1997 714.500.000 -31.01%
1998 1.068.700.000 33.14%
1999 1.499.900.000 28.75%
2000 1.648.259.000 9%
2001 1.192.263.000 -38.25%
2002 868.666.000 -37.25%
2003 836.331.000 -3.87%
2004 453.812.000 -84.29%
2005 416.200.000 -9.04%
2006 443.381.000 6.13%
2007 391.862.000 -13.15%
2008 232.402.000 -68.61%
2009 282.099.000 17.62%
2010 337.050.000 16.3%
2011 406.636.000 17.11%
2012 374.144.000 -8.68%
2013 345.996.000 -8.14%
2014 318.454.000 -8.65%
2015 257.634.000 -23.61%
2016 231.828.000 -11.13%
2017 176.464.000 -31.37%
2018 145.737.000 -21.08%
2019 107.577.000 -35.47%
2020 69.035.000 -55.83%
2021 54.028.000 -27.78%
2022 37.692.000 -43.34%
2023 22.836.000 -65.06%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Safeguard Scientifics, Inc. Liabilities
Year Liabilities Growth
1985 44.300.000
1986 96.000.000 53.85%
1987 155.300.000 38.18%
1988 200.800.000 22.66%
1989 222.400.000 9.71%
1990 205.300.000 -8.33%
1991 278.800.000 26.36%
1992 305.300.000 8.68%
1993 428.200.000 28.7%
1994 459.100.000 6.73%
1995 523.000.000 12.22%
1996 681.700.000 23.28%
1997 407.200.000 -67.41%
1998 625.900.000 34.94%
1999 822.400.000 23.89%
2000 637.360.000 -29.03%
2001 660.841.000 3.55%
2002 466.009.000 -41.81%
2003 458.001.000 -1.75%
2004 236.357.000 -93.78%
2005 240.747.000 1.82%
2006 226.009.000 -6.52%
2007 234.531.000 3.63%
2008 127.692.000 -83.67%
2009 91.592.000 -39.41%
2010 90.114.000 -1.64%
2011 58.356.000 -54.42%
2012 60.173.000 3.02%
2013 61.335.000 1.89%
2014 60.627.000 -1.17%
2015 62.129.000 2.42%
2016 62.051.000 -0.13%
2017 94.668.000 34.45%
2018 78.758.000 -20.2%
2019 5.836.000 -1249.52%
2020 6.160.000 5.26%
2021 3.462.000 -77.93%
2022 3.116.000 -11.1%
2023 2.856.000 -9.1%

Safeguard Scientifics, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.09
Net Income per Share
-0.75
Price to Earning Ratio
-0.61x
Price To Sales Ratio
5.08x
POCF Ratio
-2.22
PFCF Ratio
-2.28
Price to Book Ratio
0.37
EV to Sales
-0.48
EV Over EBITDA
0.16
EV to Operating CashFlow
0.21
EV to FreeCashFlow
0.21
Earnings Yield
-1.65
FreeCashFlow Yield
-0.44
Market Cap
0,01 Bil.
Enterprise Value
0,00 Bil.
Graham Number
4.57
Graham NetNet
0.41

Income Statement Metrics

Net Income per Share
-0.75
Income Quality
0.77
ROE
-0.44
Return On Assets
-0.53
Return On Capital Employed
-0.27
Net Income per EBT
1.23
EBT Per Ebit
1.73
Ebit per Revenue
-3.82
Effective Tax Rate
-0.15

Margins

Sales, General, & Administrative to Revenue
3.64
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
1
Operating Profit Margin
-3.82
Pretax Profit Margin
-6.61
Net Profit Margin
-8.16

Dividends

Dividend Yield
0.77
Dividend Yield %
76.92
Payout Ratio
0
Dividend Per Share
0.35

Operating Metrics

Operating Cashflow per Share
-0.2
Free CashFlow per Share
-0.2
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-0.31
Return on Tangible Assets
-0.53
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,59
Book Value per Share
1,24
Tangible Book Value per Share
1.24
Shareholders Equity per Share
1.24
Interest Debt per Share
0.22
Debt to Equity
0.06
Debt to Assets
0.05
Net Debt to EBITDA
1.92
Current Ratio
4.84
Tangible Asset Value
0,02 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
0.06
Working Capital
0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.17

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Safeguard Scientifics, Inc. Dividends
Year Dividends Growth
1997 1
1998 1 0%
2019 1 100%
2023 0 0%

Safeguard Scientifics, Inc. Profile

About Safeguard Scientifics, Inc.

Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.

CEO
Mr. Mark Dow
Employee
33
Address
150 North Radnor Chester Road
Radnor, 19087

Safeguard Scientifics, Inc. Executives & BODs

Safeguard Scientifics, Inc. Executives & BODs
# Name Age
1 Ms. Alex A. Fuiks
Associate
70
2 Mr. Seth Zuckerman
Senior Associate of Healthcare
70
3 Mr. Mark Dow
Chief Executive Officer, Chief Financial Officer & Company Secretary
70
4 Mr. G. Matthew Barnard
General Counsel, Secretary & Compliance Officer
70

Safeguard Scientifics, Inc. Competitors